vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.
SCANSOURCE, INC. is the larger business by last-quarter revenue ($766.5M vs $397.6M, roughly 1.9× Guardian Pharmacy Services, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs 2.2%, a 3.1% gap on every dollar of revenue.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.
GRDN vs SCSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $397.6M | $766.5M |
| Net Profit | $20.9M | $16.5M |
| Gross Margin | 21.5% | 13.4% |
| Operating Margin | 7.7% | 2.3% |
| Net Margin | 5.3% | 2.2% |
| Revenue YoY | — | 2.5% |
| Net Profit YoY | — | -3.3% |
| EPS (diluted) | — | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $397.6M | $766.5M | ||
| Q3 25 | $377.4M | $739.6M | ||
| Q2 25 | $344.3M | $812.9M | ||
| Q1 25 | $329.3M | $704.8M | ||
| Q4 24 | — | $747.5M | ||
| Q3 24 | $314.4M | $775.6M | ||
| Q2 24 | — | $746.1M | ||
| Q1 24 | — | $752.6M |
| Q4 25 | $20.9M | $16.5M | ||
| Q3 25 | $9.8M | $19.9M | ||
| Q2 25 | $9.0M | $20.1M | ||
| Q1 25 | $9.4M | $17.4M | ||
| Q4 24 | — | $17.1M | ||
| Q3 24 | $-122.0M | $17.0M | ||
| Q2 24 | — | $16.1M | ||
| Q1 24 | — | $12.8M |
| Q4 25 | 21.5% | 13.4% | ||
| Q3 25 | 19.8% | 14.5% | ||
| Q2 25 | 19.8% | 12.9% | ||
| Q1 25 | 19.5% | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | 19.4% | 13.1% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 12.6% |
| Q4 25 | 7.7% | 2.3% | ||
| Q3 25 | 4.3% | 3.5% | ||
| Q2 25 | 3.7% | 3.3% | ||
| Q1 25 | 3.9% | 3.2% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | -33.3% | 2.3% | ||
| Q2 24 | — | 2.9% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | 5.3% | 2.2% | ||
| Q3 25 | 2.6% | 2.7% | ||
| Q2 25 | 2.6% | 2.5% | ||
| Q1 25 | 2.9% | 2.5% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | -38.8% | 2.2% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | — | $0.75 | ||
| Q3 25 | — | $0.89 | ||
| Q2 25 | — | $0.87 | ||
| Q1 25 | — | $0.74 | ||
| Q4 24 | — | $0.70 | ||
| Q3 24 | — | $0.69 | ||
| Q2 24 | — | $0.66 | ||
| Q1 24 | — | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $83.5M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $217.9M | $910.9M |
| Total Assets | $412.7M | $1.7B |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | $83.5M | ||
| Q3 25 | $36.5M | $124.9M | ||
| Q2 25 | $18.8M | $126.2M | ||
| Q1 25 | $14.0M | $146.3M | ||
| Q4 24 | — | $110.5M | ||
| Q3 24 | $37.2M | $145.0M | ||
| Q2 24 | — | $185.5M | ||
| Q1 24 | — | $159.1M |
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $217.9M | $910.9M | ||
| Q3 25 | $195.5M | $914.0M | ||
| Q2 25 | $179.7M | $906.4M | ||
| Q1 25 | $163.2M | $901.7M | ||
| Q4 24 | — | $900.7M | ||
| Q3 24 | $133.9M | $920.9M | ||
| Q2 24 | — | $924.3M | ||
| Q1 24 | — | $944.1M |
| Q4 25 | $412.7M | $1.7B | ||
| Q3 25 | $390.0M | $1.7B | ||
| Q2 25 | $356.3M | $1.8B | ||
| Q1 25 | $334.0M | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | $348.0M | $1.8B | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $1.8B |
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.6M | $30.8M |
| Free Cash FlowOCF − Capex | — | $28.9M |
| FCF MarginFCF / Revenue | — | 3.8% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | 1.65× | 1.87× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.6M | $30.8M | ||
| Q3 25 | $28.2M | $23.2M | ||
| Q2 25 | $19.9M | — | ||
| Q1 25 | $17.6M | $66.1M | ||
| Q4 24 | — | $-6.2M | ||
| Q3 24 | — | $44.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $160.2M |
| Q4 25 | — | $28.9M | ||
| Q3 25 | $24.2M | $20.8M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $64.6M | ||
| Q4 24 | — | $-8.2M | ||
| Q3 24 | — | $42.5M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $157.7M |
| Q4 25 | — | 3.8% | ||
| Q3 25 | 6.4% | 2.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 9.2% | ||
| Q4 24 | — | -1.1% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 21.0% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | 1.1% | 0.3% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | 1.65× | 1.87× | ||
| Q3 25 | 2.87× | 1.17× | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 1.86× | 3.79× | ||
| Q4 24 | — | -0.36× | ||
| Q3 24 | — | 2.64× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 12.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRDN
Segment breakdown not available.
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
